Nasdaq GlobeNewswire

Enhesa Announces the Increase in Global Jurisdiction Coverage to 286 in 2018, and Celebrates Being Named to CIO Review's 20 Most Promising Compliance Technology Solution Providers

Del

Brussels, Belgium, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Enhesa, the leading global content provider focused on environmental, health and safety (EHS) regulatory compliance assurance support to industries worldwide, just announced the increase in global jurisdiction coverage for 2018 to reach up to 286.

Enhesa supports the Global EHS programs for many of the world's largest companies by offering a standardized, consistent suite of services enabling them to be aware of, and stay in compliance with, EHS laws wherever they operate. As a result, today, Enhesa offers off-the-shelf services in an impressive 286 jurisdictions.

New additions to the Enhesa geographic catalogue in 2018 (in English) include the following jurisdictions:

  • Argentina - Chaco
  • Argentina - Chubut
  • Azerbaijan
  • Burkina Faso
  • Canada - Northwest Territories
  • China - Guizhou
  • China - Hainan
  • China - Heilongjiang
  • Ecuador
  • German - Hanseatic City of Bremen
  • Germany - Mecklenburg - Western Pomerania
  • India Dadra -Nagar Haveli
  • India - Rajasthan
  • Macao
  • Malawi
  • Pakistan - Sindh
  • Slovenia
  • Switzerland - Solothurn
  • Switzerland - Vaud
  • Turkmenistan

Enhesa has also increased coverage by providing local language versions for the following jurisdictions:

  • Argentina - Chaco
  • Brazil - Alagoas
  • Brazil - Amazonas
  • Brazil - Maranhao
  • Brazil - Mato Grosso
  • Brazil - Parana
  • Brazil - Pernambuco
  • China - Fujian
  • China - Guizhou
  • China - Hainan
  • China - Heilongjiang
  • Guinea - National
  • Macao
  • Mali
  • Mexico - Chiapas
  • Mexico - Michoacan
  • Mexico - Quintana Roo
  • Mexico - Tlaxcala
  • Morocco
  • Paraguay
  • UAE - Abu Dhabi

Peter Hermans, Enhesa CEO further points out: "We are extremely proud of the truly global coverage we are able to offer our multinational clients. But our commitment to supporting our clients does not stop here. We will continue to partner with our current and future clients to expand our coverage as their presence around the world spreads, and provide them with the tools they need to manage EHS legal compliance at the corporate, regional, divisional and site levels."

In addition, Enhesa was selected, along with 19 other companies, to appear on CIO Review's list of "20 Most Promising Compliance Technology Solution Providers" for 2017. To help CCOs, CIOs, and CEOs find the right compliance technology provider for their enterprises, CIO Review's selection panel evaluated and shortlisted hundreds of compliance technology solution providers that are at the forefront of providing cutting-edge technology solutions.

Enhesa provides time-saving, simplified regulatory analysis translated by our in-house team of analysts - who represent approximately 45 nationalities around the world. This is why Enhesa is the leading solution to regulatory compliance forecasting and intelligence that will save you ample time and money.

To find out more about how Enhesa can help support your global EHS compliance program, please visit enhesa.com.


Company Description:

Enhesa helps global multinational companies be compliant with, and stay on top of, Environmental, Health & Safety (EHS) Regulations wherever they operate.

Enhesa's in-house team of multilingual regulatory analysts provide clear, concise and standardized content and insight on current and future EHS regulatory obligations in over 285 jurisdictions worldwide.

Enhesa's Compliance Intelligence and Regulatory Forecaster services can be provided as an automated data feed - integrated with the world's leading EHS software platforms.

Enhesa has offices in Brussels, Washington DC and Tokyo.

For more information, please visit enhesa.com or email info@enhesa.com

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ce76d13c-c729-4af3-a523-e61b4b7cc362

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1ecae2c0-6ed0-45a7-916c-f29b8c68eb53

Gloria Johnston
Enhesa
202-552-1090 ext. 203
gj@enhesa.com

Allison Gilmore
Enhesa
202-552-1090 ext. 242
agil@enhesa.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Enhesa via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21Pressemelding

BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03Pressemelding

NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can

Meltwater and Dow Jones Announce Global Partnership to Provide Premium Content18.10.2018 14:00Pressemelding

SAN FRANCISCO and NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media intelligence, today announces the launch of a partnership with Dow Jones, a global provider of news and business information, to provide premium licensed content from Dow Jones Factiva into the Meltwater Media Intelligence platform. This partnership will give Meltwater’s PR and communications clients the ability to monitor and analyze premium licensed content across thousands of Factiva news sources globally, including: The Wall Street Journal, America’s largest newspaper by paid circulation; Barron’s; MarketWatch; and Dow Jones Newswires. “Meltwater provides our clients with the most comprehensive content network globally, across news, social media and broadcast media. This new Dow Jones partnership will further strengthen our leadership position and allow our clients to access licensed content from some of the most highly-respected news outlets in the world. We’re excited about this part

Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting18.10.2018 13:30Pressemelding

EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster session. Data to be presented across the Alzheimer’s disease clinical development portfolio, including aducanumab, BAN2401 and elenbecestat CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in Barcelona, Spain (October 24-27). The data being presented are part of Biogen’s ongoing research programs targeting possible causes of the disease through multiple modalities. “We are excited to engage with the scientific community at CTAD, to share learnings from our Alzheimer’s disease clinical research and to learn from the work of our colleagues around the world. We have hopes that our

SEMAFO Provides Notice of Third Quarter 2018 Results Release and Conference Call   18.10.2018 13:30Pressemelding

MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- SEMAFO (TSX, OMX: SMF) invites you to participate in a conference call on November 7, 2018 at 10:00 AM EST with senior management during which they will review the Corporation's third quarter 2018 financial and operational results. SEMAFO's financial statements and management's discussion and analysis for the third quarter 2018 will be released on November 6 after market hours and will be available in the “Investor Relations” section of the Corporation's website at www.semafo.com , and on the Canadian Securities Administrators' website at www.sedar.com . A live audio webcast of the conference call will be accessible for a period of 30 days through SEMAFO’s website at www.semafo.com . Tel. local & overseas: +1 (647) 788 4922 Tel. North America: 1 (877) 223 4471 Webcast: www.semafo.com Replay overseas: +1 (416) 621 4642 Replay N. America: 1 (800) 585 8367 Replay pass code: 2823689 Expiration: December 7, 2018 About SEMAFO SEMAFO is a Canadian-b

Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA18.10.2018 13:30Pressemelding

TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- (CSE: BIO) – Biome Grow (“Biome” or the “Company”) (CSE:BIO) is pleased to announce that the Company’s common shares have been listed on the Frankfurt Stock Exchange under the trading symbol “6OTA”. The Company’s common shares continue to be listed on the Canadian Securities Exchange (“CSE”) under the trading symbol “BIO”. “Biome is developing its production base in Canada with an eye to becoming a leader in the international medical cannabis market. Listing on the Frankfurt Stock Exchange will give Biome increased access to European and other international investors and positions Biome well for international growth and development opportunities,” said CEO Khurram Malik. The Frankfurt Stock Exchange is one of the world’s largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany’s seven stock exchanges and it is an international trading centre, which is reflected in the structure of its

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom